| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $25.6M | — | +42.3% |
| R&D Expense | $3.3M | — | +14.5% |
| SG&A Expense | $24.3M | — | +18.6% |
| Operating Income | -$6.2M | — | +32.1% |
| Interest Expense | $2.0M | — | +17.3% |
| Income Tax | $0 | — | — |
| Net Income | -$7.8M | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $25.6M | +34.7% | +45.3% |
| Accounts Receivable | $9.5M | +5.1% | +24.4% |
| Current Assets | $40.9M | +25.8% | +38.1% |
| Total Assets | $94.6M | +8.2% | +9.7% |
| Current Liabilities | $14.5M | -16.9% | +8.8% |
| Long-term Debt |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$10.2M | — | -18.2% |
| Capital Expenditures | $81K | — | +9.5% |
| Investing Cash Flow | -$144K | — | -5.1% |
| Financing Cash Flow | $16.9M | — | — |
| Free Cash Flow | -$10.2M | — | -18.1% |
| +29.8% |
| EPS (Basic) | -$0.81 | — | -912.5% |
| EPS (Diluted) | -$0.81 | — | -912.5% |
| $50.0M |
| -0.0% |
| +24.9% |
| Total Liabilities | $85.5M | -4.9% | +13.7% |
| Stockholders' Equity | $9.1M | +470.5% | -17.4% |